Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
NCT02244346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 811
Last updated 2014-09-19
Summary
Study to evaluate the safety profile of Secotex® in the improvement of the symptoms of Benign Prostatic Hyperplasia in real clinical practice
Conditions
- Prostatic Hyperplasia
Interventions
- DRUG
-
Secotex®
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
- Primary Completion
- 2004-11-30
More Related Trials
-
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH
NCT01966614 ·Status: COMPLETED ·Phase: PHASE3
-
MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment
NCT00885027 ·Status: COMPLETED
-
Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy
NCT01566292 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade
NCT02244307 ·Status: COMPLETED
-
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
NCT00224120 ·Status: COMPLETED ·Phase: PHASE3
-
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin
NCT01330303 ·Status: COMPLETED ·Phase: PHASE1
-
Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia
NCT00889707 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
NCT01846793 ·Status: COMPLETED ·Phase: PHASE3
-
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin
NCT01262989 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Men With Benign Prostatic Hyperplasia
NCT01097707 ·Status: TERMINATED ·Phase: PHASE2
-
Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)
NCT00743184 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
NCT00970632 ·Status: COMPLETED ·Phase: PHASE3
-
Real World Data on Management of Male LUTS
NCT03075449 ·Status: COMPLETED
-
Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
NCT02245555 ·Status: COMPLETED
-
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
NCT01438775 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
NCT06568718 ·Status: COMPLETED ·Phase: NA
-
BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)
NCT01520441 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
NCT00449150 ·Status: TERMINATED ·Phase: PHASE3
-
Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH
NCT04245566 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
WEUSKOP5723: Prostate Cancer Study
NCT01767363 ·Status: COMPLETED
-
Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)
NCT00037141 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study in Benign Prostatic Hyperplasia
NCT01152190 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
NCT02431754 ·Status: COMPLETED ·Phase: PHASE4
-
RT-310 Safety and Feasibility BPH Study
NCT07264205 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)
NCT02244294 ·Status: COMPLETED ·Phase: PHASE2